Prof. Matthias Tschöp explains why multi-receptor drugs are game changers in treating obesity and preventing diabetes effectively and safely – and why they are not a “miracle treatment” for a dream body. This year, he received the Banting Medal for…
Targeted Antibody Therapy Against Brain Tumor Glioblastoma
Prof. Reinhard Zeidler about hope in the fight against glioblastoma, the most common and malignant form of brain tumor and how he accelerates the development of antibodies into application.
"A startup can be just as big a success as a Leibniz Prize!"
Matthias Tschöp, CEO of Helmholtz Munich, talks about translating scientific discoveries into clinical practice, about ambitious targets, and about ideas he acquired during his time in the USA.